Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pluri Inc.PLUR · Entity 7728 | Director | December 04, 2025 | December 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pluri Inc.
Report date December 04, 2025 · Filed December 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 144,212 |
Reported balance
After 2025-12-04 transaction · row 1
1 source rowRow 1 · 2025-12-04 · Grant · Acquired 346 · Balance 144,212 F1: The restricted stock units ("RSUs") were approved for grant by the Board of Directors on December 4, 2025, under the Company's 2019 Equity Compensation Plan. The RSUs vest equally on a monthly basis over three months following the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy Rose Hitech Ltd. | 11,472 |
Reported balance
Holding disclosure · report date 2025-12-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,472 |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units ("RSUs") were approved for grant by the Board of Directors on December 4, 2025, under the Company's 2019 Equity Compensation Plan. The RSUs vest equally on a monthly basis over three months following the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2025 Filed Dec 8, 2025 21:05 UTC | Pluri Inc. PLUR · Entity 7728 | GrantCommon Stock | 346 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-119229 · ownership.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,212 F1 · date: The restricted stock units ("RSUs") were approved for grant by the Board of Directors on December 4, 2025, under the Company's 2019 Equity Compensation Plan. The RSUs vest equally on a monthly basis over three months following the date of grant. F1 · shares: The restricted stock units ("RSUs") were approved for grant by the Board of Directors on December 4, 2025, under the Company's 2019 Equity Compensation Plan. The RSUs vest equally on a monthly basis over three months following the date of grant. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:00 UTC | Pluri Inc. PLUR · Entity 7728 | GrantCommon Stock | 14,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-017971 · ownership.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,866 F1 · date: The restricted stock units ("RSU") vest over three years as follows: 50% of RSUs will vest on a quarterly basis during the first year following the date of grant, 25% will vest on a quarterly basis during the second year following the date of grant and the remaining 25% will vest on a quarterly basis during the third year following the date of grant. F2 · balance_after: The number of shares beneficially owned reflects the 1-for-8 reverse stock split effected on April 1, 2024. F3 · balance_after: Gives effect to the expiration of RSUs that did not meet the criteria for vesting. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:01 UTC | Pluri Inc. PLUR · Entity 7728 | GrantCommon Stock | 44,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-006454 · ownership.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,536,073 F1 · date: The RSUs vest over three years as follows: 50% of RSUs will vest on a quarterly basis during the first anniversary of the date of grant, 25% will vest on a quarterly basis during the second anniversary of the date of grant and the remaining 25% will vest on a quarterly basis during the third anniversary of the date of grant. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 13:52 UTC | Pluri Inc. PLUR · Entity 7728 | SaleCommon Stock | 2,000 | $0.97 | $1,940.00 |
DisclosureSEC source: 0001213900-22-081968 · ownership.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,491,973 F1 · price: These shares were sold on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS), at per share price NIS 3.37, or $0.97 per share, for year-end tax purposes. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:00 UTC | Pluri Inc. PSTI · Entity 7728 | PurchaseCommon Stock | 80,616 | $1.80 | $145,108.80 |
DisclosureSEC source: 0001213900-22-007471 · ownership.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Rose Hitech Ltd. Disclosed balance after: 91,756 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS), at per share purchase prices ranging from NIS 5.70 to NIS 5.90, inclusive, or ranging from $1.77 to $1.82 in U.S. Dollars, inclusive (based on an exchange rate of NIS 3.221 per U.S. dollar). The Reporting Person undertakes to provide to Pluristem Therapeutics Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 20:46 UTC | Pluri Inc. PSTI · Entity 7728 | GrantRestricted Stock Units | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-026069 · ownership.xml · nonDerivative · entry 2 Aberman Zami · CIK 0001344740 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,493,973 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F3 · date: The shares vest in full upon milestone achievement of increasing market capitalization of the Issuer's common stock on the Nasdaq Capital Market to $550 million within no more than 3 years from the date of grant. F4 · balance_after: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 20:46 UTC | Pluri Inc. PSTI · Entity 7728 | GrantRestricted Stock Units | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-026069 · ownership.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 993,973 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · date: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. F4 · balance_after: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 20:17 UTC | Pluri Inc. PSTI · Entity 7728 | PurchaseCommon Stock Warrant · Derivative | 71,429 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001178913-19-001086 · zk1922908.xml · derivative · entry 3 Aberman Zami · CIK 0001344740 · Director · Co-CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,429 Underlying: Common Stock · 71,429 shares Expires 2024-04-08 F1 · price: The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I. F2 · derivative.exercise_date: The common stock warrants were exercisable immediately upon their issuance. Read SEC document |
| April 08, 2019 Filed Apr 8, 2019 20:17 UTC | Pluri Inc. PSTI · Entity 7728 | PurchaseCommon Stock | 71,429 | $0.70 | $50,000.30 |
DisclosureSEC source: 0001178913-19-001086 · zk1922908.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director · Co-CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,939,727 F1 · price: The common stock and common stock warrant were acquired in the issuer's public underwritten offering of units, in which each unit consisted of one share of common stock and an accompanying common stock warrant to purchase one share of common stock, at a price of $0.70 per unit. The price paid per unit is reflected in Table I. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 21:40 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-18-003201 · zk1822401.xml · nonDerivative · entry 2 Aberman Zami · CIK 0001344740 · Director · Co-CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,868,298 F2 · date: The shares vest as follows: 12.5% on the 27 month anniversary of the date of grant and the remaining shares vest in 7 equal installments every 3 months thereafter. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 21:40 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-18-003201 · zk1822401.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director · Co-CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,618,298 F1 · date: The shares vest as follows: 25% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 6 equal installments every 3 months thereafter. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 12:27 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-17-001887 · zk1720171.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director · Co-CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,318,298 F1 · date: The shares vest as follows: 12.5% on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. Read SEC document |
| December 29, 2016 Filed Dec 29, 2016 21:13 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-16-007196 · zk1619326.xml · nonDerivative · entry 1 Aberman Zami · CIK 0001344740 · Director · CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,318,298 F1 · date: The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.